Bellevue Group »

Apollo Medical Hldgs shares owned by Bellevue Group

Quarter-by-quarter ownership of Apollo Medical Hldgs (ASTH) shares owned by Bellevue Group from 13F filings

Historical chart of Bellevue Group investment in Apollo Medical Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Apollo Medical Hldgs held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apollo Medical Hldgs by Bellevue Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $431k 10k 41.99

More positions owned by Bellevue Group

Ionis Pharmaceuticals (IONS)
Argenx Se Sponsored Adr (ARGX)
Neurocrine Biosciences (NBIX)
Vertex Pharmaceuticals Incorporated (VRTX)
Intuitive Surgical Com New (ISRG)
Boston Scientific Corporation (BSX)
Intra Cellular Therapies (ITCI)
Moderna (MRNA)
Dex (DXCM)
Revolution Medicines (RVMD)
Abbott Laboratories (ABT)
Stryker Corporation (SYK)
Macrogenics (MGNX)
Alnylam Pharmaceuticals (ALNY)
Incyte Corporation (INCY)

View all positions for Bellevue Group

Top funds holding Apollo Medical Hldgs

BlackRock
Vanguard Group
Geode Capital Management
Dimensional Fund Advisors
Steel Peak Wealth Management
325 Capital
Fort Washington Investment Advisors
Northern Trust
Citadel Advisors
Charles Schwab Investment Management
Morgan Stanley
Bank of New York Mellon
Atria Wealth Solutions
Principal Financial Group
Ziegler Capital Management

View all funds holding Apollo Medical Hldgs